AUSTRALIA
Regulatory and Ethical Procedures
Clinical trials have to be approved by a Human Research Ethics Committee (HREC) in order to comply with the requirements of the National Health and Medical Research Council (NHMRC). The clinical research approval system is overseen by the Australian Health Ethics Committee (AHEC).

Therapeutic goods (i.e. medicines and medical devices) are regulated on a national basis within the framework of the Therapeutic Goods Act of 1989, compliance of which is overseen by the Therapeutic Goods Administration (TGA). Therapeutic goods must be approved by the TGA, and as a rule they have to be listed/registered in the Australian Register of Therapeutic Goods (ARTG).

If a clinical trial is to be conducted for therapeutic goods that are not yet entered in the ARTG, the sponsor has to obtain exemption or approval from the TGA by means of the clinical trial exemption (CTX) scheme or, more commonly, the clinical trial notification (CTN) scheme. For such trials there must be an Australian sponsor responsible for conducting the trial.
Health Care System
The Australian health system is a mixture of public and private health service providers. Government health programmes include Medicare, which is Australia's universal health insurance scheme, and the Pharmaceutical Benefits Scheme, which subsidises the cost of many prescription medicines. Australians can receive free treatment as public patients in a public hospital. Contribution to the health care system is made through taxes and a Medicare levy based on income. Private health insurance can be arranged to cover additional services.
Authorities
Therapeutic Goods Administration (TGA)
National Health and Medical Research Council (NHMRC)
Health Insurance Commission (HIC)